by healthadvances Posted on May 16, 2023 Winning the China Market: A Review of NRDL Inclusions Read More
by healthadvances Posted on September 7, 2022 Part Two: The Emergence of Chinese MedTech on the Global Stage Read More
by healthadvances Posted on June 30, 2021 Tencent-Backed Wedoctor Is Going Public: What Are the Next Steps for Chinese Digital Health Companies? Read More
by healthadvances Posted on September 15, 2020 Hong Kong Exchange: Nurturing China’s Biotech Valley Read More
by healthadvances Posted on May 8, 2020 How COVID-19 is Accelerating Telemedicine Adoption in Asia Pacific Read More
by healthadvances Posted on April 13, 2020April 20, 2020 Medtech Geographic Launch Sequences Warrant Reevaluation Read More
by healthadvances Posted on March 30, 2020April 13, 2020 Key Trends and Developments in the Chinese Oncology Market Read More
by healthadvances Posted on December 4, 2019April 13, 2020 Australian Biotechs and Medtechs: Look to the East Read More
by healthadvances Posted on November 18, 2019April 13, 2020 Changes in China: How Can Medtech Companies Succeed? (Part Two) Read More
by healthadvances Posted on November 11, 2019April 13, 2020 Changes in China: How Can Medtech Companies Succeed? (Part One) Read More
by healthadvances Posted on April 7, 2019April 13, 2020 Keytruda, a case study for the improved regulatory environment in China Read More
by healthadvances Posted on March 27, 2019April 13, 2020 Improvements in China Drug Registration – Opening the Door to the China Market for Global BioPharma Read More
